are they going to stop making compounded semaglutide (GLP-1) Compounded' weight-loss drugs are a

All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only

Despite its decision to scrap the drug, Pfizer on Monday said those studies met key goals and confirmed a certain form and dose of the pill with the potential to deliver "competitive efficacy and tolerability" in late-stage trials

This threatens the reputation of compounding that is done safely and by the book, Todd Harrison, partner and co-chair of the FDA Group at law firm Venable, told us

Leatherhead Food Researchs latest report, GLP-1 Support Foods for Weight Management, explores the key regulatory considerations across 17 markets, including: How foods marketed as GLP 1 support foods may be classified within existing regulatory categories Where the line sits between general nutritional messaging and regulated health or functional claims How differing regulatory pathways across global markets can affect labelling, substantiation requirements and speed to market Global regulatory diversity is already emerging One of the defining features of this category is the lack of global harmonisation

When your levels drop, your body feels the effects

Glucagon-like peptide-1 receptor agonist use and the risk of adverse cardiac and kidney outcomes among patients with systemic lupus erythematosus and lupus nephritis